Cicalese, Maria Pia (2015) New approaches in management and treatment of primary immunodeficiencies and other genetic diseases. [Tesi di dottorato]

[img]
Preview
Text
cicalese_mariapia_27-2.pdf

Download (36MB) | Preview
[error in script] [error in script]
Item Type: Tesi di dottorato
Lingua: English
Title: New approaches in management and treatment of primary immunodeficiencies and other genetic diseases.
Creators:
CreatorsEmail
Cicalese, Maria Piamariapia.cicalese@tiscali.it
Date: 30 March 2015
Number of Pages: 312
Institution: Università degli Studi di Napoli Federico II
Department: Scienze Mediche Traslazionali
Scuola di dottorato: Medicina clinica e sperimentale
Dottorato: Riproduzione, sviluppo ed accrescimento dell'uomo
Ciclo di dottorato: 27
Coordinatore del Corso di dottorato:
nomeemail
Pignata, Claudiopignata@unina.it
Tutor:
nomeemail
Pignata, ClaudioUNSPECIFIED
Date: 30 March 2015
Number of Pages: 312
Uncontrolled Keywords: Primary immunodeficiencies, gene therapy, Duchenne Muscular Dystrophy, cellular therapy, bone marrow transplantation, children.
Settori scientifico-disciplinari del MIUR: Area 05 - Scienze biologiche > BIO/10 - Biochimica
Area 05 - Scienze biologiche > BIO/12 - Biochimica clinica e biologia molecolare clinica
Area 05 - Scienze biologiche > BIO/13 - Biologia applicata
Area 06 - Scienze mediche > MED/07 - Microbiologia e microbiologia clinica
Area 06 - Scienze mediche > MED/15 - Malattie del sangue
Area 06 - Scienze mediche > MED/38 - Pediatria generale e specialistica
Additional Information: Il mio programma di dottorato è stato svolto presso HSR TIGET (San Raffaele Institute for Gene Therapy) di Milano. Pertanto, oltre al tutor, Prof. Claudio Pignata, sarà presente quale co-tutor da HSR-TIGET il Prof. Alessandro Aiuti.
Date Deposited: 10 Apr 2015 12:36
Last Modified: 23 Apr 2018 01:00
URI: http://www.fedoa.unina.it/id/eprint/10131
DOI: 10.6093/UNINA/FEDOA/10131

Abstract

During my PhD program in "Human Reproduction, Development and Growth" (XXVII Cycle, years 2011-2014), I contributed to the development of new approaches for the treatment of PIDs and other genetic diseases by advanced therapies, such as gene and cellular therapy. Moreover, I participated in the clinical and biological characterization of patients with immunodeficiencies and in the implementation of new approaches for the clinical management of children affected by hematological and immunological disorders undergoing bone marrow transplantation. My other lines of research have been focused on the use of new drugs in pediatric population, characterization of severe and unusual conditions and description of the State of the Art of known patologies in childhood.

Actions (login required)

View Item View Item